Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience

被引:0
|
作者
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
Rosenberg, S. A. [1 ]
Horning, S. J. [1 ]
机构
[1] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:27 / 27
页数:1
相关论文
共 50 条
  • [21] Cardiac risk after mediastinal irradiation for Hodgkin's disease
    Glanzmann, C
    Kaufmann, P
    Jenni, R
    Hess, OM
    Huguenin, P
    RADIOTHERAPY AND ONCOLOGY, 1998, 46 (01) : 51 - 62
  • [22] Prognostic evaluation of stage I and II subdiaphragmatic Hodgkin's disease.
    Levis, A
    Ricardi, U
    Gavarotti, P
    Allione, B
    Baraldi, A
    Bertini, M
    Depaoli, L
    Gallamini, A
    Pini, M
    Pistone, M
    Cambrin, GR
    Scalabrini, DR
    Salvi, F
    Scassa, E
    Tonso, A
    Vitolo, U
    Botto, B
    Tarella, C
    Gallo, E
    BLOOD, 1999, 94 (10) : 514A - 514A
  • [23] Chemotherapy alone in the treatment of stage I and II Hodgkin's disease.
    Dimopoulos, MA
    Kostourou, A
    Karmiris, T
    Mellou, S
    Pavlidis, N
    Papassavas, P
    Dervenoulas, I
    Papageorgiou, S
    Nikiforakis, E
    Economopoulos, T
    BLOOD, 1998, 92 (10) : 625A - 625A
  • [24] Radiation following chemotherapy for mediastinal Hodgkin's disease: the outcome of various doses for bulky tumors
    Eisbruch, A
    Kazerooni, EA
    Sahijdak, WM
    Francis, IR
    Lichter, AS
    RADIOTHERAPY AND ONCOLOGY, 1998, 46 (01) : 47 - 49
  • [25] Late relapse after treatment for clinical stage I and II Hodgkin's disease
    Brierley, JD
    Rathmell, AJ
    Gospodarowicz, MK
    Sutcliffe, SB
    Pintillie, M
    CANCER, 1997, 79 (07) : 1422 - 1427
  • [26] The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone
    Provencio, M
    España, P
    Millán, I
    Sánchez, A
    Cantos, B
    Bonilla, F
    LEUKEMIA & LYMPHOMA, 2003, 44 (02) : 263 - 268
  • [27] Site of relapse after chemotherapy atone for stage I and II Hodgkin's disease
    Shahidi, M
    Kamangari, N
    Ashley, S
    Cunningham, D
    Horwich, A
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 (01) : 1 - 5
  • [28] Risk of cardiac damage after mediastinal radiotherapy for Hodgkin's disease
    Buglione, M.
    Trevisan, F.
    Baushi, L.
    Triggiani, M.
    Pasinetti, N.
    Alghisi, A.
    Greco, D.
    Papa, A.
    Spiazzi, L.
    Borghetti, P.
    Nodari, S.
    Magrini, S.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S313 - S314
  • [29] Subdiaphragmatic stage I & II Hodgkin's disease - Long-term follow-up and prognostic factors
    Liao, ZX
    Ha, CS
    Fuller, LM
    Hagemeister, FB
    Cabanillas, F
    Tucker, SL
    Hess, MA
    Cox, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 322 - 322
  • [30] Subdiaphragmatic Stage I & II Hodgkin's disease: Long-term follow-up and prognostic factors
    Liao, ZX
    Ha, CS
    Fuller, LM
    Hagemeister, FB
    Cabanillas, F
    Tucker, SL
    Hess, MA
    Cox, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (05): : 1047 - 1056